GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gan & Lee Pharmaceuticals Co Ltd (SHSE:603087) » Definitions » Cyclically Adjusted PS Ratio

Gan & Lee Pharmaceuticals Co (SHSE:603087) Cyclically Adjusted PS Ratio : 11.62 (As of Jun. 05, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Gan & Lee Pharmaceuticals Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Gan & Lee Pharmaceuticals Co's current share price is ¥56.45. Gan & Lee Pharmaceuticals Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 was ¥4.86. Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio for today is 11.62.

The historical rank and industry rank for Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:603087' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.68   Med: 9.03   Max: 11.75
Current: 11.75

During the past 12 years, Gan & Lee Pharmaceuticals Co's highest Cyclically Adjusted PS Ratio was 11.75. The lowest was 7.68. And the median was 9.03.

SHSE:603087's Cyclically Adjusted PS Ratio is ranked worse than
89.05% of 484 companies
in the Medical Devices & Instruments industry
Industry Median: 2.215 vs SHSE:603087: 11.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Gan & Lee Pharmaceuticals Co's adjusted revenue per share data of for the fiscal year that ended in Dec24 was ¥5.153. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥4.86 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Gan & Lee Pharmaceuticals Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gan & Lee Pharmaceuticals Co Cyclically Adjusted PS Ratio Chart

Gan & Lee Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 7.61 11.56 9.07

Gan & Lee Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 9.07 -

Competitive Comparison of Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio falls into.


;
;

Gan & Lee Pharmaceuticals Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=56.45/4.86
=11.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gan & Lee Pharmaceuticals Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Gan & Lee Pharmaceuticals Co's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=5.153/114.8925*114.8925
=5.153

Current CPI (Dec24) = 114.8925.

Gan & Lee Pharmaceuticals Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 2.395 100.600 2.735
201612 3.485 102.600 3.903
201712 4.688 104.500 5.154
201812 4.729 106.500 5.102
201912 5.729 111.200 5.919
202012 6.310 111.500 6.502
202112 6.440 113.108 6.542
202212 3.039 115.116 3.033
202312 4.601 114.781 4.605
202412 5.153 114.893 5.153

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Gan & Lee Pharmaceuticals Co  (SHSE:603087) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Gan & Lee Pharmaceuticals Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Gan & Lee Pharmaceuticals Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gan & Lee Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, 1st Nanfeng West Road, Zhenxian Town, Tongzhou District, Beijing, CHN, 101102
Gan & Lee Pharmaceuticals Co Ltd is a biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues in the diabetes market in China. The company is engaged in production and sales of recombinant insulin analog raw materials and injections. It has launched multiple biosimilar insulin analogue products, including the super long-acting insulin glargine Basalin, the super quick-acting insulin lispro Prandilin, and the pre-mixed insulin analogue Prandilin 25.
Executives
Gan Zhong Ru Director

Gan & Lee Pharmaceuticals Co Headlines

No Headlines